Standards of Care Updates from the ADA
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1 agonists as first-line injection therapy, and CGM metrics Continue Reading
.png?itok=1zUPmh3S "New Insulin Affordability Programs Include $99...")
.png?itok=kKA0p5hX&c=5ee60a69fdb27313f610d3b1667924a4)
.jpg?itok=NKQZ3nq6&c=20073634d31ecff9a550b5264fef1094)
.jpg?itok=iWOwploE&c=3b8472e37f383b9aa67d7b10ed36c8fe)
_0.jpg?itok=Bfl22gFS&c=0712dc2c92b36f9300169a226f4996da)
